Suppr超能文献

一位透析存活半个世纪者:临床及尸检结果

A Half-Century Dialysis Survivor: Clinical and Autopsy Findings.

作者信息

Okubo Noto, Suwabe Tatsuya, Oba Yuki, Ikuma Daisuke, Mizuno Hiroki, Sekine Akinari, Hasegawa Eiko, Yamanouchi Masayuki, Hoshino Junichi, Kitajima Izuru, Shiba Masanori, Uruga Koki, Takeshi Fuji, Ohashi Kenichi, Sawa Naoki, Ubara Yoshifumi

机构信息

Nephrology Center and Okinawa Memorial Institute for Medical Research, Toranomon Hospital, Kajigaya, Japan.

Department of Orthopedic Surgery, Toranomon Hospital, Tokyo, Japan.

出版信息

Kidney Med. 2023 Feb 7;5(4):100612. doi: 10.1016/j.xkme.2023.100612. eCollection 2023 Apr.

Abstract

A man in his 20s initiated intermittent peritoneal dialysis in the late 1960s. He subsequently transitioned to hemodialysis and survived for more than 50 years, spanning low-flux and high-flux hemodialysis eras. He underwent surgery for cervical and lumbar spinal canal stenosis after 30 and 35 years, respectively, and both surgeries revealed similar degrees of severe amyloid deposition. At autopsy, significant improvement was seen in lumbar amyloid deposition. During the previous 25 years, serum β2 microglobulin levels had decreased from 40 mg/L and been maintained at 20 mg/L. This case indicates that advances in dialysis therapy aimed at lowering β2 microglobulin concentrations have reduced highly deposited amyloid.

摘要

一名20多岁的男子于20世纪60年代末开始进行间歇性腹膜透析。随后他转为血液透析,并存活了50多年,经历了低通量和高通量血液透析时代。他分别在30年和35年后接受了颈椎和腰椎管狭窄手术,两次手术均显示出相似程度的严重淀粉样蛋白沉积。尸检时,腰椎淀粉样蛋白沉积有显著改善。在之前的25年里,血清β2微球蛋白水平从40mg/L下降并维持在20mg/L。该病例表明,旨在降低β2微球蛋白浓度的透析治疗进展减少了高度沉积的淀粉样蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3030/10006697/9b196e11c892/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验